On December 21, 2022, Rubius Therapeutics, Inc. (the "Company") reported it completed its previously announced sale of certain real property located at 100 Technology Way, Smithfield, Rhode Island 02917 (Map 49, Lot 219) and 30 Hanton City Road, Smithfield, Rhode Island 02917 (Map 49, Lot 78), together with the buildings and improvements thereon, including the Company’s manufacturing facility, and certain fixtures and personal property located in or on the real property (collectively, the "Property"), as previously described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 12, 2022 (the "Prior Report") (Filing, 8-K, Rubius Therapeutics, DEC 21, 2022, View Source [SID1234625504]). As previously described in the Prior Report, the Company sold the Property to DIV Acquisition V, LLC for an aggregate purchase price of $18,500,000, subject to adjustment.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!